-
EP2925358
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2925358
| EP2925358 - ANTI-PAD2 ANTIBODIES AND TREATMENT OF AUTOIMMUNE DISEASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.07.2016 Database last updated on 31.08.2024 | Most recent event Tooltip | 01.07.2016 | Application deemed to be withdrawn | published on 03.08.2016 [2016/31] | Applicant(s) | For all designated states Rigshospitalet Blegdamsvej 9 2100 København Ø / DK | [2015/41] | Inventor(s) | 01 /
NIELSEN, Claus Henrik Solvænget 10 2800 Kgs. Lyngby / DK | 02 /
DAMGAARD, Dres Ungarnsgade 12, 4th 2300 København S / DK | [2015/41] | Representative(s) | Høiberg P/S Adelgade 12 1304 Copenhagen K / DK | [N/P] |
| Former [2015/41] | Høiberg A/S St. Kongensgade 59 A 1264 Copenhagen K / DK | Application number, filing date | 13811115.8 | 02.12.2013 | [2015/41] | WO2013DK50406 | Priority number, date | DK20120070747 | 03.12.2012 Original published format: DK 201270747 | [2015/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014086365 | Date: | 12.06.2014 | Language: | EN | [2014/24] | Type: | A1 Application with search report | No.: | EP2925358 | Date: | 07.10.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.06.2014 takes the place of the publication of the European patent application. | [2015/41] | Search report(s) | International search report - published on: | EP | 12.06.2014 | Classification | IPC: | A61K39/395, A61P37/00, C07K16/40 | [2015/41] | CPC: |
C07K16/40 (EP,US);
A61P37/00 (EP);
C07K2317/21 (US);
C07K2317/24 (US);
C07K2317/33 (EP,US);
C07K2317/565 (US);
C07K2317/76 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/41] | Title | German: | ANTI-PAD2-ANTIKÖRPER UND BEHANDLUNG VON AUTOIMMUNKRANKHEITEN DAMIT | [2015/41] | English: | ANTI-PAD2 ANTIBODIES AND TREATMENT OF AUTOIMMUNE DISEASES | [2015/41] | French: | ANTICORPS ANTI-PAD2 ET TRAITEMENT DE MALADIES AUTO-IMMUNES | [2015/41] | Entry into regional phase | 03.07.2015 | National basic fee paid | 03.07.2015 | Designation fee(s) paid | 03.07.2015 | Examination fee paid | Examination procedure | 03.07.2015 | Examination requested [2015/41] | 10.02.2016 | Application deemed to be withdrawn, date of legal effect [2016/31] | 16.03.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2016/31] | Fees paid | Renewal fee | 08.12.2015 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [ID]WO2010005293 (CHIRALIX B V [NL], et al) [ID] 1-40 * example 10 *; | [XA] - RACHIDA NACHAT ET AL, "Peptidylarginine Deiminase Isoforms 1-3 Are Expressed in the Epidermis and Involved in the Deimination of K1 and Filaggrin", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (20050201), vol. 124, no. 2, doi:10.1111/j.0022-202X.2004.23568.x, ISSN 0022-202X, pages 384 - 393, XP055099050 [X] 24 * figures 1,2 * [A] 1-23,25-40 DOI: http://dx.doi.org/10.1111/j.0022-202X.2004.23568.x | [XA] - NOBUKO SHIMADA ET AL, "Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain", JOURNAL OF NEUROSCIENCE RESEARCH, (20090101), doi:10.1002/jnr.22255, ISSN 0360-4012, pages NA - NA, XP055099036 [X] 24 * column 799, line r, paragraph 4 - page 800, line l, paragraph 1; figure 1 * [A] 1-23,25-40 DOI: http://dx.doi.org/10.1002/jnr.22255 | [I] - BENJAMIN AC FISHER ET AL, "Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire", ARTHRITIS RESEARCH & THERAPY, (20120101), vol. 14, no. 1, doi:10.1186/ar1184, ISSN 1478-6354, page 108, XP055098834 [I] 1-40 * the whole document * DOI: http://dx.doi.org/10.1186/ar3740 | [I] - J. A. HILL ET AL, "Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20080317), vol. 95, no. 25, doi:10.1073/pnas.95.25.14863, ISSN 0027-8424, pages 14863 - 979, XP055099127 [I] 1-40 * page 973; table S4 * DOI: http://dx.doi.org/10.1073/pnas.95.25.14863 | by applicant | WO2010005293 | WO2011050357 | WO2009127048 | EP1717224 | WO2012026309 | WO2012143523 | - FOULQUIER ET AL., ARTHRITIS & RHEUMATISM, (2007), vol. 56, no. 11, pages 3541 - 53 | - SUZUKI ET AL., NAT. GENET., (2003), vol. 34, no. 4, pages 395 - 402 | - GYORGY ET AL., INT J BIOCHEM CELL BIOL, (2006), vol. 38, pages 1662 - 77 | - FOULQUIER ET AL., ARTHRITIS RHEUM, (2007), vol. 56, pages 3541 - 53 | - MUSSE ET AL., DISEASE MODELS & MECHANISMS, (2008), vol. 1, pages 229 - 240 | - MAKRYGIANNAKIS ET AL., ANN RHEUM DIS, vol. 67, pages 1488 - 92 | - PARDRIDGE ET AL., METHODS ENZYMOL, (2012), vol. 503, pages 269 - 92 | - CHINTALACHARUVU ET AL., "Chimeric Antibodies: Production and Applications", METHODS, (1995), vol. 8, no. 2, pages 73 - 82 | - ALMAGRO; FRANSSON, FRONT BIOSCI., (2008), vol. 13, pages 1619 - 1633 | - BURKS ET AL., PNAS USA, (1997), vol. 94, pages 412 - 417 | - WU ET AL., PNAS USA, (1998), vol. 95, pages 6037 - 6042 | - KOHLER; MILSTEIN, J. IMMUNOL., (1975), vol. 174, pages 2453 - 5 |